News of the WeekBiotechnology

Disease Group Invests in Do-It-Yourself Drugs

Science  09 Jun 2000:
Vol. 288, Issue 5472, pp. 1715-1717
DOI: 10.1126/science.288.5472.1715b

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

On 31 May, the Cystic Fibrosis (CF) Foundation of Bethesda, Maryland, announced that it will invest at least $30 million in a small biotech firm, Aurora Biosciences of San Diego, to identify compounds that might prove useful in treating CF. This project, fueled initially by a donation of $20 million from the Bill and Melinda Gates Foundation, marks a new departure in the growing trend of patient groups taking charge of biomedical research.

Related Content